This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback